<DOC>
	<DOC>NCT00721188</DOC>
	<brief_summary>The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.</brief_summary>
	<brief_title>Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Ferric oxide, saccharated</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<criteria>Age &gt; or = 12 to &lt; or = 16 years Parent and/or legal guardian able to give informed consent Subject able to give written assent for participating in the study NDDCKD defined as: kidney damage for 3 months or longer, or GFR &lt; 60 for 3 months or longer Hemoglobin indicative of anemia Ferritin indicative of iron deficiency anemia If appropriate, subject must be willing to use an accepted form of birth control from time of screening through the followup period Known history of hypersensitivity to any component of Venofer Parenteral iron within 14 days of the screening visit Dialysis dependentCKD Chronic or serious active infection Pregnancy or lactation Subjects with causes of iron deficiency anemia other than CKD Blood transfusion within the last month or anticipated during the study Body weight &lt; 55 pounds Received an investigational drug within 30 days before screening</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>